{"product_id":"the-world-market-for-liquid-biopsy-2023","title":"The World Market for Liquid Biopsy, 2023","description":"\u003cp\u003eThe World Market for Liquid Biopsy, 2023\u003c\/p\u003e\n\n\u003cp\u003eDramatic changes have occurred in the liquid biopsy market, necessitating a resource to provide perspective on the market opportunity. This new report from Kalorama assesses the Liquid Biopsy Market now and in 2027.  The report can be useful for business planning, market share assessment, competitive research, and due diligence for mergers and acquisitions and other partnerships.\u003c\/p\u003e \n\n\u003cp\u003eLiquid biopsy is gaining acceptance each year.  Even through the COVID-19 pandemic, announcements of new liquid biopsy products were made and studies conducted to assess the capability of these tests in clinical diagnostics uses.  While tissue biopsies and imaging techniques remain the current standards of care in the diagnosis of solid tumors, they have risks and limitations and limitations, some of which can be overcome by the use of liquid biopsy in clinical oncology, as an alternative or complementary technique to the current standards of care.\u003c\/p\u003e\n\n\u003cp\u003eThis report, The World Liquid Biopsy Market, 2023, from Kalorama Information, contains up-to-date information and useful data points for business planning:\u003c\/p\u003e\n\n\u003cp\u003eThe Market for Liquid Biopsy by RegionNorth AmericaEuropeAsiaRest of WorldThe Market for CTC-based Liquid BiopsyGrowth to 2027The Market for ctDNA-based Liquid BiopsyGrowth to 2027The Market for EV and Exosome-based Liquid BiopsyGrowth to 2027The Market for Multi-Analyte-based Liquid BiopsyGrowth to 2027The Market for Other Analytes Liquid BiopsyGrowth to 2027Liquid Biopsy Market by Type of Cancer BreastLungColorectalOvarianProstatePan-CancerOther CancerR\u0026amp;D: Selected ctDNA-based Liquid Biopsy Tests in Development\u003c\/p\u003e\n\n\u003cp\u003eOn the Market: Selected Market-Available CTC-based Liquid Biopsy Tests, 2021\u003c\/p\u003e\n\n\u003cp\u003eOn the Market: Selected Liquid Biopsy Tests That Assess Multiple Analytes, 2021\u003c\/p\u003e\n\n\u003cp\u003eLiquid biopsy testing has many potential applications in aspects of clinical oncology, including:Early detection and diagnosis \/ screeningAlternative testing method when tissue biopsy is difficult\/impossible, or when the primary site of metastatic disease is unknownTherapy personalization and monitoring – by molecular characterization of a patient’s disease, clinicians can select the optimal course of therapy and monitor efficacy over time, as well as quickly react to adjust therapy should treatment resistance ariseDisease monitoring – to observe disease progression, tumor evolution, residual disease, and early detection of recurrenceThese applications, increasing acceptance, the use of liquid biopsy in combination with other technologies.   This report contains market assessments for these application categories.\u003c\/p\u003e  \n\n\u003cp\u003eIn addition, the report profiles key companies in the market, including: Adaptive Biotechnologies\t   Agena Bioscience, Inc.\t    Angle, PLC\t    Aspira Women’s Health\t    Biocartis Group Nv\t    Biocept, Inc.\t   Biodesix\t    Cellmax Life\t   Circulogene\t   Diacarta, Inc.\t   Epic Sciences\t   Epigenomics AG\t    Exact Sciences\t   Exosome Diagnostics, Inc.\t   Foundation Medicine, Inc. (Roche)\t   Freenome, Inc.\t   Gilupi Gmbh\t   Grail (Illumina)\t   Guardant Health, Inc.\t    Hologic\t   Lunglife AI (Formerly Cynvenio Biosystems)\t   Menarini-Silicon Biosystems, SPA\t   Myriad Genetics, Inc.\t    Natera, Inc.\t     Neogenomics Laboratories, Inc.\t    Oncocyte Corporation\t     Oncodna S.A.\t    Personal Genome Diagnostics\t   Qiagen N.V.\t   Cell-Free DNA Technologies\t   Ctc Technologies\t   Exosome And Mirna Technologies\t   Resolution Biosciences (Agilent)\t   Roche Diagnostics\t   Sysmex-Inostics, Inc.\t    Tempus\t   \t    Volitionrx\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"December, 2022 \/ 211 Pages \/ MCW16225223","offer_id":47639645192498,"sku":null,"price":7200.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/the-world-market-for-liquid-biopsy-2023","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}